Steven Barger
Concepts (347)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 15 | 2025 | 332 | 4.630 |
Why?
| | Brain | 18 | 2025 | 1323 | 2.670 |
Why?
| | Glutamic Acid | 12 | 2023 | 104 | 2.480 |
Why?
| | Microglia | 13 | 2023 | 113 | 2.430 |
Why?
| | Amyloid beta-Peptides | 6 | 2025 | 66 | 2.380 |
Why?
| | Neurons | 17 | 2022 | 418 | 2.160 |
Why?
| | Gene Expression Regulation | 10 | 2016 | 990 | 1.800 |
Why?
| | Amyloid beta-Protein Precursor | 8 | 2018 | 22 | 1.690 |
Why?
| | NF-kappa B | 7 | 2016 | 322 | 1.610 |
Why?
| | Racemases and Epimerases | 8 | 2012 | 18 | 1.410 |
Why?
| | Apolipoproteins E | 5 | 2023 | 55 | 1.320 |
Why?
| | Animals | 48 | 2025 | 13505 | 1.180 |
Why?
| | Serine | 9 | 2022 | 36 | 0.990 |
Why?
| | Astrocytes | 4 | 2020 | 137 | 0.940 |
Why?
| | Prescription Drugs | 1 | 2025 | 41 | 0.930 |
Why?
| | Cells, Cultured | 20 | 2016 | 1567 | 0.930 |
Why?
| | Mice, Transgenic | 9 | 2023 | 552 | 0.880 |
Why?
| | Insulin | 3 | 2020 | 479 | 0.780 |
Why?
| | Peptide Fragments | 3 | 2020 | 203 | 0.770 |
Why?
| | Glucose Transporter Type 1 | 1 | 2020 | 17 | 0.700 |
Why?
| | Rats | 18 | 2016 | 3220 | 0.690 |
Why?
| | Sp1 Transcription Factor | 4 | 2009 | 20 | 0.640 |
Why?
| | Transcription Factor AP-1 | 2 | 2012 | 61 | 0.610 |
Why?
| | Somatomedins | 1 | 2018 | 30 | 0.610 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2018 | 17 | 0.610 |
Why?
| | Rats, Sprague-Dawley | 13 | 2019 | 1563 | 0.590 |
Why?
| | Blood Glucose | 2 | 2020 | 473 | 0.590 |
Why?
| | Membrane Proteins | 4 | 2018 | 335 | 0.580 |
Why?
| | Gene Expression | 4 | 2020 | 618 | 0.570 |
Why?
| | Transcription, Genetic | 3 | 2009 | 378 | 0.560 |
Why?
| | Central Nervous System | 2 | 2016 | 76 | 0.550 |
Why?
| | Neurochemistry | 1 | 2016 | 2 | 0.530 |
Why?
| | Nerve Tissue Proteins | 3 | 2023 | 187 | 0.530 |
Why?
| | LDL-Receptor Related Proteins | 1 | 2016 | 7 | 0.530 |
Why?
| | Presenilin-1 | 1 | 2016 | 8 | 0.530 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 4 | 2022 | 79 | 0.530 |
Why?
| | Diet, High-Fat | 2 | 2018 | 236 | 0.530 |
Why?
| | Interleukin-1beta | 2 | 2019 | 86 | 0.510 |
Why?
| | Mice | 20 | 2024 | 5949 | 0.510 |
Why?
| | Obesity | 3 | 2020 | 1162 | 0.510 |
Why?
| | Humans | 33 | 2025 | 52483 | 0.500 |
Why?
| | Genetic Therapy | 1 | 2016 | 121 | 0.490 |
Why?
| | Neuroglia | 2 | 2012 | 39 | 0.480 |
Why?
| | Neuroprotective Agents | 3 | 2007 | 101 | 0.480 |
Why?
| | Animals, Newborn | 8 | 2014 | 362 | 0.470 |
Why?
| | Neurodegenerative Diseases | 2 | 2007 | 80 | 0.460 |
Why?
| | Inflammation | 4 | 2011 | 641 | 0.450 |
Why?
| | DNA Methylation | 1 | 2018 | 592 | 0.430 |
Why?
| | Frontotemporal Dementia | 1 | 2013 | 4 | 0.430 |
Why?
| | Superoxide Dismutase | 3 | 2012 | 119 | 0.420 |
Why?
| | Promoter Regions, Genetic | 3 | 2012 | 467 | 0.420 |
Why?
| | Mutation | 3 | 2016 | 1347 | 0.420 |
Why?
| | Epigenesis, Genetic | 1 | 2016 | 406 | 0.410 |
Why?
| | Presynaptic Terminals | 1 | 2012 | 14 | 0.400 |
Why?
| | Apolipoprotein E4 | 3 | 2024 | 22 | 0.400 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2012 | 16 | 0.400 |
Why?
| | Cytokines | 3 | 2017 | 623 | 0.400 |
Why?
| | Glycogen Synthase Kinase 3 | 2 | 2015 | 21 | 0.400 |
Why?
| | Interleukin-1alpha | 1 | 2012 | 10 | 0.390 |
Why?
| | Oxidation-Reduction | 3 | 2011 | 326 | 0.390 |
Why?
| | Reactive Nitrogen Species | 1 | 2012 | 23 | 0.380 |
Why?
| | Cysteine | 1 | 2011 | 49 | 0.370 |
Why?
| | Signal Transduction | 7 | 2023 | 1671 | 0.370 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 185 | 0.370 |
Why?
| | Dose-Response Relationship, Drug | 7 | 2015 | 1378 | 0.360 |
Why?
| | Neuronal Plasticity | 2 | 2016 | 45 | 0.350 |
Why?
| | Sp4 Transcription Factor | 2 | 2009 | 2 | 0.350 |
Why?
| | Hippocampus | 3 | 2018 | 201 | 0.350 |
Why?
| | Reactive Oxygen Species | 2 | 2013 | 421 | 0.350 |
Why?
| | RNA, Small Interfering | 4 | 2016 | 213 | 0.340 |
Why?
| | Extracellular Matrix Proteins | 2 | 2023 | 69 | 0.330 |
Why?
| | Serine Endopeptidases | 2 | 2023 | 50 | 0.330 |
Why?
| | Aging | 3 | 2022 | 701 | 0.330 |
Why?
| | Male | 14 | 2025 | 26761 | 0.330 |
Why?
| | Drug Interactions | 4 | 2012 | 206 | 0.310 |
Why?
| | RNA, Messenger | 9 | 2018 | 1132 | 0.310 |
Why?
| | Plaque, Amyloid | 1 | 2008 | 14 | 0.300 |
Why?
| | Lipopolysaccharides | 5 | 2012 | 206 | 0.300 |
Why?
| | Schwann Cells | 2 | 2005 | 14 | 0.290 |
Why?
| | Transcription Factors | 2 | 2016 | 566 | 0.280 |
Why?
| | Interleukin-1 | 2 | 2005 | 107 | 0.280 |
Why?
| | Cystine | 2 | 2023 | 11 | 0.280 |
Why?
| | Receptors, Glutamate | 1 | 2007 | 5 | 0.270 |
Why?
| | Sp3 Transcription Factor | 1 | 2007 | 5 | 0.270 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2007 | 16 | 0.270 |
Why?
| | Lithium Chloride | 1 | 2007 | 6 | 0.270 |
Why?
| | Calpain | 1 | 2007 | 23 | 0.270 |
Why?
| | Lipid Peroxidation | 1 | 2007 | 97 | 0.270 |
Why?
| | Embryo, Mammalian | 4 | 2016 | 67 | 0.260 |
Why?
| | Neurobiology | 1 | 2006 | 5 | 0.260 |
Why?
| | Female | 11 | 2025 | 28171 | 0.250 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2011 | 72 | 0.250 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2006 | 137 | 0.250 |
Why?
| | Nerve Growth Factors | 2 | 2006 | 28 | 0.250 |
Why?
| | Electrophoretic Mobility Shift Assay | 4 | 2017 | 74 | 0.250 |
Why?
| | Apolipoprotein E3 | 2 | 2023 | 9 | 0.240 |
Why?
| | Protein Binding | 5 | 2017 | 667 | 0.240 |
Why?
| | Case-Control Studies | 4 | 2025 | 1201 | 0.240 |
Why?
| | Kynurenic Acid | 1 | 2005 | 3 | 0.240 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2005 | 94 | 0.240 |
Why?
| | Amyloid Precursor Protein Secretases | 2 | 2016 | 11 | 0.240 |
Why?
| | Amino Acid Isomerases | 1 | 2004 | 2 | 0.240 |
Why?
| | Intellectual Property | 1 | 2004 | 4 | 0.230 |
Why?
| | S100 Proteins | 1 | 2005 | 34 | 0.230 |
Why?
| | Cognition | 2 | 2023 | 331 | 0.230 |
Why?
| | Research Support as Topic | 1 | 2004 | 44 | 0.230 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 582 | 0.230 |
Why?
| | Antiporters | 1 | 2023 | 19 | 0.220 |
Why?
| | Genotype | 2 | 2023 | 566 | 0.220 |
Why?
| | Blotting, Western | 4 | 2013 | 590 | 0.210 |
Why?
| | Cerebral Cortex | 5 | 2013 | 198 | 0.210 |
Why?
| | Transcription Factor RelA | 2 | 2016 | 32 | 0.210 |
Why?
| | tau Proteins | 3 | 2016 | 27 | 0.210 |
Why?
| | Cooperative Behavior | 1 | 2004 | 227 | 0.200 |
Why?
| | Enzyme Inhibitors | 4 | 2012 | 372 | 0.200 |
Why?
| | Mice, Inbred C57BL | 5 | 2016 | 1884 | 0.190 |
Why?
| | N-Methylaspartate | 1 | 2022 | 18 | 0.190 |
Why?
| | Caenorhabditis elegans | 2 | 2024 | 139 | 0.190 |
Why?
| | Lysosomes | 2 | 2024 | 76 | 0.190 |
Why?
| | Oxygen | 1 | 2004 | 336 | 0.190 |
Why?
| | Cell Adhesion Molecules, Neuronal | 2 | 2023 | 9 | 0.190 |
Why?
| | Metformin | 1 | 2022 | 76 | 0.190 |
Why?
| | Aged, 80 and over | 2 | 2025 | 3392 | 0.180 |
Why?
| | Glucose | 1 | 2023 | 355 | 0.180 |
Why?
| | Cohort Studies | 1 | 2025 | 1542 | 0.180 |
Why?
| | Autophagy | 2 | 2024 | 193 | 0.170 |
Why?
| | Analysis of Variance | 3 | 2013 | 554 | 0.170 |
Why?
| | Fluorescent Antibody Technique | 3 | 2011 | 111 | 0.170 |
Why?
| | DNA-Binding Proteins | 1 | 2002 | 422 | 0.160 |
Why?
| | Risk | 1 | 2020 | 316 | 0.160 |
Why?
| | Ubiquitination | 1 | 2019 | 47 | 0.160 |
Why?
| | Risk Factors | 2 | 2025 | 3889 | 0.160 |
Why?
| | Nitrites | 2 | 2012 | 31 | 0.160 |
Why?
| | Models, Biological | 3 | 2007 | 735 | 0.160 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2019 | 96 | 0.150 |
Why?
| | Insulysin | 1 | 2018 | 2 | 0.150 |
Why?
| | Animals, Genetically Modified | 1 | 2018 | 52 | 0.150 |
Why?
| | Proteomics | 2 | 2018 | 329 | 0.150 |
Why?
| | Carbon | 1 | 2018 | 55 | 0.140 |
Why?
| | Nucleotide Motifs | 1 | 2017 | 23 | 0.140 |
Why?
| | D-Amino-Acid Oxidase | 2 | 2008 | 2 | 0.140 |
Why?
| | Disease Models, Animal | 4 | 2023 | 1478 | 0.130 |
Why?
| | Aged | 3 | 2025 | 10121 | 0.130 |
Why?
| | Carrier Proteins | 1 | 2018 | 313 | 0.130 |
Why?
| | Insulin Resistance | 1 | 2018 | 275 | 0.130 |
Why?
| | Cell Line, Transformed | 2 | 2017 | 74 | 0.130 |
Why?
| | TNF Receptor-Associated Factor 2 | 1 | 2016 | 3 | 0.130 |
Why?
| | I-kappa B Kinase | 1 | 2016 | 20 | 0.130 |
Why?
| | Glycoside Hydrolases | 1 | 2016 | 18 | 0.130 |
Why?
| | TNF Receptor-Associated Factor 6 | 1 | 2016 | 8 | 0.130 |
Why?
| | Autoradiography | 1 | 2016 | 32 | 0.130 |
Why?
| | Forecasting | 1 | 2016 | 154 | 0.120 |
Why?
| | Blood-Brain Barrier | 1 | 2016 | 48 | 0.120 |
Why?
| | Transfection | 2 | 2007 | 357 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 235 | 0.120 |
Why?
| | Anthracenes | 2 | 2005 | 9 | 0.120 |
Why?
| | RNA Interference | 2 | 2013 | 181 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2013 | 185 | 0.110 |
Why?
| | Calnexin | 1 | 2014 | 5 | 0.110 |
Why?
| | Calreticulin | 1 | 2014 | 10 | 0.110 |
Why?
| | Luciferases | 2 | 2023 | 48 | 0.110 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2020 | 560 | 0.110 |
Why?
| | Cell Death | 3 | 2016 | 177 | 0.110 |
Why?
| | Cell Nucleus | 2 | 2006 | 187 | 0.110 |
Why?
| | Middle Aged | 2 | 2025 | 13028 | 0.110 |
Why?
| | Social Behavior Disorders | 1 | 2013 | 6 | 0.110 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2013 | 29 | 0.110 |
Why?
| | Proteasome Inhibitors | 1 | 2014 | 104 | 0.100 |
Why?
| | Superoxides | 1 | 2013 | 46 | 0.100 |
Why?
| | Neocortex | 2 | 2014 | 7 | 0.100 |
Why?
| | Neural Stem Cells | 1 | 2013 | 26 | 0.100 |
Why?
| | Phosphorylation | 4 | 2018 | 528 | 0.100 |
Why?
| | Retrospective Studies | 1 | 2025 | 6607 | 0.100 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 804 | 0.100 |
Why?
| | 1-Methyl-3-isobutylxanthine | 1 | 2012 | 8 | 0.100 |
Why?
| | Excitatory Amino Acid Agents | 1 | 2012 | 2 | 0.100 |
Why?
| | Liver | 1 | 2018 | 1156 | 0.100 |
Why?
| | Dioxolanes | 1 | 2012 | 15 | 0.100 |
Why?
| | Purines | 1 | 2012 | 34 | 0.100 |
Why?
| | Pentaerythritol Tetranitrate | 1 | 2012 | 2 | 0.100 |
Why?
| | 3-Mercaptopropionic Acid | 1 | 2012 | 2 | 0.100 |
Why?
| | Spermine | 1 | 2012 | 4 | 0.100 |
Why?
| | Hypoxanthine | 1 | 2012 | 5 | 0.100 |
Why?
| | Pentetic Acid | 1 | 2012 | 7 | 0.100 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2012 | 4 | 0.100 |
Why?
| | Nitric Oxide Donors | 1 | 2012 | 9 | 0.100 |
Why?
| | Hydroxyl Radical | 1 | 2012 | 6 | 0.100 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 50 | 0.100 |
Why?
| | Peroxynitrous Acid | 1 | 2012 | 33 | 0.100 |
Why?
| | Angiotensin II | 1 | 2013 | 162 | 0.100 |
Why?
| | Chelating Agents | 1 | 2012 | 31 | 0.100 |
Why?
| | Oxidants | 1 | 2012 | 51 | 0.100 |
Why?
| | Protein Structure, Quaternary | 1 | 2011 | 26 | 0.090 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2012 | 33 | 0.090 |
Why?
| | Protein Multimerization | 1 | 2011 | 56 | 0.090 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 120 | 0.090 |
Why?
| | Retina | 1 | 2011 | 63 | 0.090 |
Why?
| | Diabetic Retinopathy | 1 | 2011 | 44 | 0.090 |
Why?
| | Cell Line | 3 | 2018 | 1030 | 0.090 |
Why?
| | Pregnancy | 1 | 2018 | 2680 | 0.090 |
Why?
| | Mass Spectrometry | 1 | 2012 | 292 | 0.090 |
Why?
| | Recombinant Proteins | 1 | 2011 | 483 | 0.080 |
Why?
| | Kinetics | 1 | 2011 | 626 | 0.080 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2011 | 137 | 0.080 |
Why?
| | DNA | 2 | 2004 | 549 | 0.080 |
Why?
| | Amino Acids | 1 | 2012 | 377 | 0.080 |
Why?
| | Neurogenic Inflammation | 1 | 2009 | 3 | 0.080 |
Why?
| | Prosencephalon | 1 | 2009 | 9 | 0.080 |
Why?
| | I-kappa B Proteins | 1 | 2009 | 16 | 0.080 |
Why?
| | Neurogenesis | 1 | 2009 | 27 | 0.080 |
Why?
| | Reversal Learning | 1 | 2008 | 5 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2013 | 1023 | 0.080 |
Why?
| | Disease Susceptibility | 1 | 2009 | 95 | 0.080 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2022 | 50 | 0.080 |
Why?
| | Extinction, Psychological | 1 | 2008 | 34 | 0.080 |
Why?
| | Time Factors | 2 | 2005 | 2968 | 0.070 |
Why?
| | Nitriles | 2 | 2005 | 53 | 0.070 |
Why?
| | Schizophrenia | 1 | 2009 | 254 | 0.070 |
Why?
| | Models, Molecular | 2 | 2019 | 348 | 0.070 |
Why?
| | Acetophenones | 1 | 2007 | 12 | 0.070 |
Why?
| | Onium Compounds | 1 | 2007 | 13 | 0.070 |
Why?
| | Butadienes | 2 | 2005 | 49 | 0.070 |
Why?
| | Sp Transcription Factors | 1 | 2006 | 6 | 0.070 |
Why?
| | HIV | 1 | 2006 | 25 | 0.070 |
Why?
| | Ischemic Attack, Transient | 1 | 2007 | 57 | 0.070 |
Why?
| | Vitamin E | 1 | 2007 | 77 | 0.060 |
Why?
| | Reperfusion Injury | 1 | 2007 | 70 | 0.060 |
Why?
| | Immunoglobulins | 1 | 2006 | 76 | 0.060 |
Why?
| | alpha-Synuclein | 1 | 2006 | 9 | 0.060 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2007 | 339 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2003 | 155 | 0.060 |
Why?
| | 2-Amino-5-phosphonovalerate | 1 | 2005 | 4 | 0.060 |
Why?
| | Tetrazolium Salts | 1 | 2005 | 15 | 0.060 |
Why?
| | Culture Media, Conditioned | 1 | 2005 | 47 | 0.060 |
Why?
| | Nerve Degeneration | 1 | 2005 | 24 | 0.060 |
Why?
| | Bone Marrow Cells | 1 | 2006 | 190 | 0.060 |
Why?
| | Antioxidants | 1 | 2007 | 256 | 0.060 |
Why?
| | Age Factors | 1 | 2008 | 1132 | 0.060 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2005 | 46 | 0.060 |
Why?
| | Thiazoles | 1 | 2005 | 55 | 0.060 |
Why?
| | Respiratory Burst | 1 | 2004 | 4 | 0.060 |
Why?
| | Microtubule-Associated Proteins | 1 | 2005 | 65 | 0.060 |
Why?
| | Glutamates | 1 | 2004 | 21 | 0.060 |
Why?
| | Mutagenesis | 1 | 2004 | 61 | 0.060 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 82 | 0.060 |
Why?
| | Sciatic Nerve | 1 | 2004 | 19 | 0.060 |
Why?
| | Stem Cells | 1 | 2006 | 177 | 0.060 |
Why?
| | Cloning, Molecular | 1 | 2004 | 190 | 0.060 |
Why?
| | Drug Combinations | 1 | 2005 | 132 | 0.060 |
Why?
| | Memory | 1 | 2005 | 100 | 0.060 |
Why?
| | Receptors, Lipoprotein | 1 | 2004 | 7 | 0.060 |
Why?
| | Imidazoles | 1 | 2005 | 124 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2004 | 39 | 0.050 |
Why?
| | Adaptation, Physiological | 1 | 2004 | 110 | 0.050 |
Why?
| | Pyridines | 1 | 2005 | 132 | 0.050 |
Why?
| | Anti-Inflammatory Agents | 1 | 2004 | 166 | 0.050 |
Why?
| | Synaptophysin | 1 | 2003 | 7 | 0.050 |
Why?
| | Calcium | 1 | 2005 | 376 | 0.050 |
Why?
| | Learning | 1 | 2005 | 160 | 0.050 |
Why?
| | Receptors, LDL | 1 | 2023 | 71 | 0.050 |
Why?
| | Palmitates | 1 | 2022 | 29 | 0.050 |
Why?
| | Cell Fractionation | 1 | 2002 | 10 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2018 | 879 | 0.050 |
Why?
| | Hypothalamus | 1 | 2022 | 44 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 2002 | 7 | 0.050 |
Why?
| | Lipoprotein Lipase | 1 | 2002 | 14 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2023 | 229 | 0.050 |
Why?
| | Genes, Reporter | 1 | 2002 | 88 | 0.050 |
Why?
| | Dexamethasone | 1 | 2004 | 438 | 0.050 |
Why?
| | Fibroblasts | 1 | 2004 | 355 | 0.050 |
Why?
| | Protein Kinase C | 1 | 2002 | 68 | 0.050 |
Why?
| | Oligonucleotides | 1 | 2002 | 76 | 0.050 |
Why?
| | Isoenzymes | 1 | 2002 | 166 | 0.050 |
Why?
| | Disease Progression | 2 | 2017 | 871 | 0.050 |
Why?
| | Adipocytes | 1 | 2002 | 132 | 0.050 |
Why?
| | Ubiquitin | 1 | 2019 | 47 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2004 | 807 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2019 | 270 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 180 | 0.040 |
Why?
| | Mitochondria | 1 | 2022 | 430 | 0.040 |
Why?
| | Synaptosomes | 1 | 2018 | 14 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2018 | 27 | 0.040 |
Why?
| | Receptor, Insulin | 1 | 2018 | 37 | 0.040 |
Why?
| | Epistasis, Genetic | 1 | 2017 | 31 | 0.040 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 20 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2017 | 88 | 0.030 |
Why?
| | Cell Differentiation | 2 | 2013 | 665 | 0.030 |
Why?
| | Intermediate Filament Proteins | 1 | 2016 | 12 | 0.030 |
Why?
| | Detergents | 1 | 2016 | 15 | 0.030 |
Why?
| | Computer Simulation | 1 | 2017 | 290 | 0.030 |
Why?
| | 14-3-3 Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 108 | 0.030 |
Why?
| | Solubility | 1 | 2016 | 79 | 0.030 |
Why?
| | Oxidopamine | 1 | 2014 | 3 | 0.030 |
Why?
| | Brefeldin A | 1 | 2014 | 16 | 0.030 |
Why?
| | Protein Disulfide-Isomerases | 1 | 2014 | 14 | 0.030 |
Why?
| | Antibodies | 2 | 2006 | 159 | 0.030 |
Why?
| | Adrenergic Agents | 1 | 2014 | 15 | 0.030 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 5 | 0.030 |
Why?
| | Cytokine Receptor gp130 | 1 | 2013 | 14 | 0.030 |
Why?
| | Exploratory Behavior | 1 | 2013 | 24 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 111 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2013 | 86 | 0.030 |
Why?
| | Cell Count | 1 | 2013 | 149 | 0.030 |
Why?
| | Psychomotor Agitation | 1 | 2013 | 51 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 105 | 0.030 |
Why?
| | Interpersonal Relations | 1 | 2013 | 106 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2013 | 164 | 0.020 |
Why?
| | Adult | 1 | 2008 | 14161 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2013 | 278 | 0.020 |
Why?
| | Parkinson Disease | 1 | 2014 | 155 | 0.020 |
Why?
| | Streptozocin | 1 | 2011 | 24 | 0.020 |
Why?
| | Aqueous Humor | 1 | 2011 | 10 | 0.020 |
Why?
| | Autistic Disorder | 1 | 2013 | 126 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 1470 | 0.020 |
Why?
| | Random Allocation | 1 | 2011 | 285 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 454 | 0.020 |
Why?
| | Body Weight | 1 | 2011 | 523 | 0.020 |
Why?
| | Pedigree | 1 | 2009 | 125 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2009 | 163 | 0.020 |
Why?
| | Maze Learning | 1 | 2008 | 35 | 0.020 |
Why?
| | Peripheral Nervous System | 1 | 2004 | 16 | 0.010 |
Why?
| | Child, Preschool | 1 | 2013 | 4076 | 0.010 |
Why?
| | Phagocytes | 1 | 2004 | 11 | 0.010 |
Why?
| | Scavenger Receptors, Class B | 1 | 2004 | 10 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2004 | 106 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2004 | 53 | 0.010 |
Why?
| | Receptors, Scavenger | 1 | 2004 | 29 | 0.010 |
Why?
| | Polysaccharides | 1 | 2004 | 57 | 0.010 |
Why?
| | Biological Transport | 1 | 2004 | 160 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 2003 | 11 | 0.010 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2003 | 18 | 0.010 |
Why?
| | Interferon-gamma | 1 | 2004 | 180 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2006 | 979 | 0.010 |
Why?
| | Phenotype | 1 | 2006 | 789 | 0.010 |
Why?
| | Coculture Techniques | 1 | 2003 | 144 | 0.010 |
Why?
| | Polyribosomes | 1 | 2002 | 7 | 0.010 |
Why?
| | Protein Kinase C-alpha | 1 | 2002 | 10 | 0.010 |
Why?
| | Cell Communication | 1 | 2003 | 71 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2002 | 46 | 0.010 |
Why?
| | Oligonucleotides, Antisense | 1 | 2002 | 30 | 0.010 |
Why?
| | MAP Kinase Signaling System | 1 | 2002 | 121 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2004 | 478 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 399 | 0.010 |
Why?
| | Child | 1 | 2013 | 7248 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2002 | 258 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2004 | 1222 | 0.010 |
Why?
|
|
Barger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|